|
References-
Part 2 of paper
(part
1)
Is
a Positive Western Blot Proof of HIV Infection?
Bio/Technology Vol.11 June 1993
Eleni
Papadopulos-Eleopulos, Valendar F. Turner and John M. Papadimitriou
Acknowledgements
We wish to
thank all our colleagues and especially Udo SchEklenk, Barry Page,
Bruce Hedland-Thomas, David Causer, Richard Fox, John Peacock, David
Prentice, Ronald Hirsch, Patricia Shalala, Keith Jones, Alun Dufty,
June Rider Jones, Coronary Barrow, Dorothy Davis, Julian Smith,
Mark Strahan, Vincent Turner, Wallace Turner and Graham Drabble
for their continued support and assistance.
Dedication
This work is
dedicated to the memory of Methodios Papadopulos and Margaret Joan
Turner.
Authors:
Eleni Papadopulos-Eleopulos,
Physicist
Department of Medical Physics
Royal Perth Hospital
Valendar F.
Turner, Staff Specialist
Department of Emergency Medicine
Royal Perth Hospital
John M. Papadimitriou
Professor of Pathology
Department of Pathology
University of Western Australia
Correspondence
to:
Eleni Papadopulos-Eleopulos
Department of Medical Physics
Royal Perth Hospital
Box X2213 GPO Perth
Captions
for figures 0-4.
Figure 0.(left
out with publication)
WB patterns
with patient sera "and reaction with a strong, weak and non-reactive
control". (Reproduced from Bio-Rad Laboratory Manual).
Figure 1.
(A): "Cord
blood T-lymphocytes infected with virus" (HIV-1) were lysed
and the supernatant of a 10,000g centrifugation of the cell lysate
was immunoprecpitated with sera from patients with lymphadenopathy
(P); a healthy donor (h); goat antiserum to HTLV-I p24 (G); normal
goat serum (g).
(B): As 1A
but cells infected with HTLV-I instead of HIV-1. 2C: The cell free
supernatant from the cultures of "cord blood T-lymphocytes
infected with virus" (HIV-1) was ultracentrifuged for one hour
at 50,000 rev/min.The pellett was banded in sucrose density gradients.
Material which banded at 1.16gm/ml (the complete virus) was immunoprecipitated
with the above sera but instead of normal goat serum, serum from
another healthy donor (h) was used. Although in the published strips
it is hard if not impossible to distinguish any bands, in the text,
it is stated that "three major proteins could be seen: the
p25 protein and proteins with molecular weights of 80,000 and 45,000"
(Modifed from BarrG-Sinoussi et al. Science Vol 220:p870).
Figure 2.
(A): "Lysates
of HTLV-III producer" H4 clone cells, derived from the HUT78
cell line immunoprecipitated with various sera.
(B): "Lysates
of HTLV-III producer" H17 clone cells also derived from the
HUT78 cell line, immunoprecipitated with various sera; (the serum
in B lane 2 is identical to (A) Lane 4).
(C): Lysates
of H17 and H4 clones (b) "before" and (a) "after
infection", immunoprecipitated with serum from a male heterosexual
drug user with lymphandenopathy and thrombocytopenia (pre-AIDS).
This is the same serum as (B) Lane 5.
(D): "Lysates
of H4/HTLV-III... cells" (C), or "virus purified from
the cells culture fluids", (V), using (I)-same serum as (B)
Lane 5; (II)-serum from a patient with pre-AIDS; (III) serum from
a patient with AIDS. This is the same serum as (B) Lane 4.
Key to sera:
(A) AIDS patient; (P) pre-AIDS patient; (h) healthy control; (U)
drug user; (H) homosexual control; (Modified from Schubach et al
1984. Science Vol 224:p504).
Figure 3.
WB of one and
the same serum specimen tested by 19 laboratories. (From Lundberg
GD 1988. JAMA Vol 260:p676).
Figure 4.
Structural
model of HIV. From reference 107.
References
1. Ratner,
L., Haseltine, W., Patarca, R.P. et al. 1985. Complete nucleotide
sequence of the AIDS virus, HTLV-III. Nature 313:277-284.
2. Hausmann,
E.H.S., Gelderblom, H.R., Clapham, P.R. et al. 1987. Detection of
HIV envelope specific antibodies by immunoelectron microscopy and
correlation with antibody titer and virus neutralizing activity.
J. Virol. Meth. 16:125-137.
3. Pinter,
A., Honnen, W.J., Tilley, S.A. et al. 1989. Oligomeric Structure
of gp41,the Transmembrane Protein of Human Immunodeficiency Virus
Type 1. J. Virol. 63:2674-2679.
4. BarrG-Sinoussi,
F., Chermann, J.C., Rey, F. et al. 1983. Isolation of a T-Lymphotrophic
Retrovirus from a patient at Risk for Acquired Immune Deficiency
Syndrome (AIDS). Science 220:868-871.
5. SchEpbach,
J., Popovic, M., Gilden, R.V. et al. 1984. Serological analysis
of a Subgroup of Human T-Lymphotrophic Retroviruses (HTLV-III) Associated
with AIDS. Science 224:503-505.
6. Damsky,
C.H., Sheffield, J.B., Tuszynski, G.P. et al. 1977. Is there a role
for Actin in Virus Budding? J. Cell. Biol. 75:593-605.
7. Stanislawsky,
L., Mongiat, F., Neto, V.M. et al 1984. Presence of Actin in Oncornaviruses.
Biochem. Biophys. Res. Com. 118:580-586.
8. Papadopulos-Eleopulos,
E., Turner, V.F. and Papadimitriou, J.M. 1992. Oxidative stress,
HIV and AIDS. Res. Immunol. 143:145-148.
9. Hinshaw,
D.B., Burger, J.M., Beals, T.F. et al. 1991. Actin polymerization
in cellular oxidant injury. Arch. Biochem. Biophys. 228:311-316.
10. Bach, M.A.,
Lewis, D.E., McClure, J.E. et al. 1986. Monoclonal Anti-actin Antibody
Recognizes a Surface Molecule on Normal and Transformed Human B
Lymphocytes:Expression Varies with Phase of Cell Cycle. Cell. Immunol.
98:364-374.
11. Stricker,
R.B., Abrams, D.I., Corash, L. et al. 1985. Target Platelet Antigen
in Homosexual Men with Immune Thrombocytopenia. NEJM 313:1375-1380.
12. Henderson,
L.E., Sowder, R., Copeland, T.D. et al. 1987. Direct Identification
of Class II Histocompatibility DR Proteins in Preparations of Human
T-Cell Lymphotropic Virus Type III. J. Virol. 61:629-632.
13. Wong-Staal,
F. and Gallo, R.C. 1985. Human T-lymphotropic retroviruses. Nature
317:395-403.
14. Genesca,
J., Jett, B.W., Epstein, J.S. et al. 1989. What do Western Blot
indeterminate patterns for Human Immunodeficiency Virus mean in
EIA-negative blood donors? Lancet II:1023-1025.
15. Ranki,
A., Johansson, E. and Krohn, K. 1988. Interpretation of Antibodies
Reacting Solely with Human Retroviral Core Proteins. NEJM 318:448-449.
16. Delord,
B., Ottmann, M., Schrive, M.H. et al. 1991. HIV-1 expression in
25 infected patients:A comparison of RNA PCR, p24 EIA in Plasma
and in situ Hybridization in mononuclear cells, p113. In: Vol. I,
Abstracts VII International Conference on AIDS,Florence.
17. Todak,
G., Klein, E., Lange, M. et al. 1991. A clinical appraisal of the
p24 Antigen test, p326. In:Vol. I, Abstracts VII International Conference
on AIDS,Florence.
18. Courouce,
A., Muller, J. and Richard, B. 1986. False-Positive Western Blot
Reactions to Human Immunodeficiency Virus in Blood Donors. Lancet
II:921-922.
19. Stricker,
R.B., McHugh, T.M., Moody, D.J. et al. 1987. An AIDS-related Cytotoxic
autoantibody reacts with a specific antigen on stimulated CD4+ T
cells. Nature 327:710-713.
20. Chassagne,
J., Verelle, P., Fonck, Y. et al. 1986. Detection of the Lymphadenopathy-Associated
Virus p18 in cells of patients with Lymphoid Diseases using a Monoclonal
Antibody. Ann. Inst. Pasteur/Immunol. 137D:403-408.
21. Parravicini,
C.L., Klatzmann, D., Jaffray, P. et al. 1988. Monoclonal Antibodies
to the human immunodeficiency virus p18 protein cross-react with
normal human tissues. AIDS 2:171-177.
22. Matsiota,
P., Chamaret, S., Montagnier, L. et al. 1987. Detection of Natural
Autoantibodies in the serum of Anti-HIV Positive-Individuals. Ann.
Inst. Pasteur/Immunol. 138:223-233.
23. Popovic,
M., Sarngadharan, M.G., Read, E. et al 1984. Detection, Isolation,and
Continuous Production of Cytopathic Retroviruses (HTLV-III) from
Patients with AIDS and Pre-AIDS. Science 224:497-500.
24. Wilber,
J.C. 1991. New Developments in Diagnosing Infections, p.1-15. In:AIDS
Clinical Review, P. Volbering, M.A. Jacobson (Eds.). Marcel Dekker
Inc. New York.
25. Lundberg,
G.D. 1988. Serological Diagnosis of Human Immunodeficiency Virus
Infection by Western Blot Testing. JAMA 260:674-679.
26. Zolla-Pazner,
S., Gorny, M.K. and Honnen, W.J. 1989. Reinterpretation of Human
Immunodeficiency Virus Western Blot Patterns. NEJM 320:1280-1281.
27. Burke,
D.S. 1989. Laboratory Diagnosis of Human Immunodeficiency Virus
Infection. Clin. Lab. Med. 9:369-392.
28. Maskill,
W.J. and Gust, I.D. 1992. HIV-1 Testing in Australia. Australian
Prescriber 15:11-13.
29. DeCock,
K.M., Selik, R.M., Soro, B. et al. 1991. AIDS surveillance in Africa:a
reappraisal of case definitions. BMJ 303:1185-1189.
30. Voevodin,
A. 1992. HIV screening in Russia. Lancet 339:1548.
31. Working
Group on AIDS Case Definition 1990. Epidemiol. Bull. 4:9-11.
32. Edwards,
V.M., Mosley, J.W. and the Transfusion Safety Study Group. 1991.
Reproducibility in Quality Control of Protein (Western) Immunoblot
Assay for Antibodies to Human Immunodeficiency Virus. Am. J. Clin.
Pathol. 91:75-78.
33. CDC. 1989.
Interpretation and Use of the Western Blot Assay for Serodiagnosis
of Human Immunodeficiency Virus Type 1 Infections. MMWR 38 No. S-7:1-7.
34. Weiss,
S.H., Goedert, J.J., Sarngadharan, M.G. et al. 1985. Screening Test
for HTLV-III (AIDS Agent) Antibodies. JAMA 253:221-225.
35. Weiss,
R. and Thier, S.O. 1988. HIV testing is the answer-what's the question?
NEJM 319:1010-1012.
36.Burke, D.S.,
Brundage, J.F., Redfield, R.R. et al. 1988. Measurement of the False
Positive Rate in a Screening Program for Human Immunodeficiency
Virus Infections. NEJM 319:961-964.
37. Scarlatti,
G.S., Lombardi, V., Plebani, A. et al. 1991. Polymerase chain reaction,
virus isolation and antigen assay in HIV-1-antibody-positive mothers
and their children. AIDS 5:1173-1178.
38. Griner,
P.F., Mayewski, R.J., Mushlin, A.I. et al. 1981. Selection and Interpretation
of Diagnostic Tests and Procedures. Ann. Int. Med. 94 (Part 2):559-563.
39. CDC. 1987.
Revision of the CDC Surveillance Case Definition for Acquired Immunodeficiency
Syndrome. JAMA 258:1143-1145.
40. Conley,
C.L. and Savarese, D. 1989. Biologic False-Positive Serologic Tests
for Syphilis and Other Serologic Abnormalities in Autoimmune Hemolytic
Anemia and Thromobocytopenic Purpura. Medicine 68:67-84.
41. Boue, F.,
Dreyfus, M., Bridley, F. et al. 1990. Lupus anticoagulant and HIV
infection:a prospective study. AIDS 4:467-471.
42. Jaffe,
J.H., Moore, J.D., Cone, E.J. et al. 1986. HTLV-III Seropositivity
in 1971-1972 Parenteral Drug Abusers-A case of false Positives or
Evidence of Viral Exposure? NEJM 314:1387-1388.
43. Biggar,
R.J., Gigase, P.L., Melbye, M. et al. 1985. ELISA HTLV Retrovirus
Antibody Reactivity Associated with Malaria and Immune Complexes
in Healthy Africans. Lancet II:520-523.
44. Ternynck,
T. and Avrameas, S. 1986. Murine Natural Monoclonal Autoantibodies:
A Study of their Polyspecificities and their Affinities. Immunol.
Rev. 94:99-112.
45. Pateraki,
E., Kaklamani, E., Portocalas, K.R. et al. 1986. Autoantibodies
in systemic lupus erythematosus and normal subjects. Clin. Rheumatol.
5:338-345.
46. Morton,
D.L. and Malmgren, R.A. 1968. Human Osteosarcomas:Immunologic Evidence
suggesting an associated agent. Science 162:1279-1281.
47. Hirshaut,
Y., Pei, D.T., Marcove, R.C. et al. 1974. Seroepidemiology of Human
Sarcoma Antigen (S1). NEJM 291:1103-1107.
48. Kurth,
R., Teich, N.M., Weiss, R. et al. 1977. Natural human antibodies
reactive with primate type-C viral antigens. Proc. Natl. Acad. Sci.
74:1237-1241.
49. Snyder,
H.W. and Fleissner, E. 1980. Specificity of human antibodies to
oncovirus glycoproteins:Recognition of antigen by natural antibodies
directed against carbohydrate structures. Proc. Natl. Acad. Sci.
77:1622-1626.
50. Barbacid,
M., Bolognesi, D. and Aaronson, S.A. 1980..Humans have antibodies
capable of recognizing oncoviral glycoproteins:Demonstration that
these antibodies are formed in response to cellular modification
of glycoproteins rather than as consequence of exposure to virus.
Proc. Natl. Acad. Sci. 77:1617-1621.
51. Essex,
M., McLane, M.F., Lee, T.H. et al. 1983. Antibodies to Cell Membrane
Antigens Associated with Human T-Cell Leukemia Virus in Patients
with AIDS. Science 220:859-862.
52. Novick,
D.M., Des Jarlais, D.C., Kreek, M.J. et al. 1988. Specificity of
Antibody Tests for Human Immunodeficiency Virus in Alcohol and Parenteral
Drug Abusers with Chronic Liver Disease. Alcoholism Clin Exp Res
12:687-690.
53. European
Collaborative Study. 1991. Children born to women with HIV-1 infection:natural
history and risk of transmission. Lancet 337:253-260.
54. Beneviste,
R.E., Ochs, H.D., Fischer, S.H. et al. 1986. Screening for antibodies
to LAV/HTLV-III in recipients of immunoglobulin preparations. Lancet
I:1090-1092.
55. Burinsky,
K.I., Chaplinskas, S.A., Syrtsev, V.A. et al. 1988. Reactivity to
gag- and env-related sequences in immunoblot assay is not necessarily
indicative of HIV infection. AIDS 2:405-406.
56. Calabrese,
L.H. 1988. Autoimmune Manifestations of Human Immunodeficiency Virus
(HIV) Infection. Clin. Lab. Med. 8:269-279.
57. Bonara,
P., Maggioni, L. and Colombo, G. 1991. Anti-Lymphocyte Antibodies
and Progression of Disease in HIV Infected Patients,p.149. In:Vol.
II, VII International Conference on AIDS,Florence.
58. Tumietto,
F., Costigliola, P., Ricchi, E. et al. 1991. Anti-Lymphocyte Auto-antibodies:Evaluation
and correlation with different stages of HIV Infection,p149. In:Vol.
II, VII International Conference on AIDS,Florence.
59. Morozov,
V.A., Ilyinskii, P.O., Uckert, W.A. et al. 1989. Antibodies to structural
and nonstructural gag-coded proteins of type-D retroviruses in human
with lymphadenopathy and AIDS. Int. J. Tiss. Reac. XI:1-5.
60. Lucey,
D.R., Hendrix, C.W., Andrzejewski, C. et al. 1992. Comparison by
Race of Total Serum IgG,IgA,and IgM with CD4+ T-Cell Counts in North
American Persons Infected with the Human Immunodeficiency Virus
Type 1. J. Acquir. Immun. Defic. Syndr. 5:325-332.
61. Papadopulos-Eleopulos,
E. 1988. Reappraisal of AIDS:Is the oxidation induced by the risk
factors the primary cause? Med. Hypotheses 25:151-162
62. Papadopulos-Eleopulos,
E., Turner, V.F. and Papadimitriou, J. 1992. Kaposi's sarcoma and
HIV. Med. Hypotheses 39:22-29.
63. Igel, H.J.,
Turner, H.C., Kotin, P. et al. 1969. Mouse Leukaemia Virus Activation
by Chemical Carcinogens. Science 166:624-1626.
64.Sterk, C.
1988. Cocaine and HIV Seropositivity. Lancet I:1052-1053.
65. Kion, T.A.
and Hoffmann, G.W. 1991. Anti-HIV and Anti-Anti-MHC Antibodies in
Alloimmune and Autoimmune Mice. Science 253:1138-1140.
66. Conley,
L.J. and Holmerg, S.D. 1992. Transmission of AIDS from blood screened
negative for antibody to the human immunodeficiency virus. NEJM
326:1499.
67. Burgher,
H., Weiser, B., Robinson, W.S. et al. 1985. Transient Antibody to
Lymphadenopathy-Associated/Human T-Lymphotrophic Virus Type III
and T-Lymphocyte Abnormalities in the Wife of a Man who Developed
the Acquired Immunodeficiency Syndrome. Ann. Int. Med. 103:545-547.
68. Esteva,
M.H., Blasini, A.M., Ogly, D. and Rodriguez, M.A. 1992. False positive
results from antibody to HIV in two men with systemic lupus erythrematosus.
Ann. Rhem. Dis. 51:1071-1073.
69. Dummer,
J.S., Erb, S., Breinig, M.K. et al. 1989. Infection with Human Immunodeficiency
Virus in the Pittsburgh Transplant Population. Transplantation 47:134-139.
70. Pitchenik,
A.E., Burr, J., Suarez, M. et al. 1987. Human T-Cell Lymphotrophic
Virus-III (HTLV-III) Seropositivity and Related Disease Among 71
Consecutive Patients in Whom Tuberculosis was Diagnosed. Am. Rev.
Respir. Dis. 135:875-879.
71. Nzilambi,
N., Mann, J.M., Francis, H. et al. 1986. Seroprevalence among tuberculosis
patients in Zaire. In:Abstracts II International AIDS Conference,
Paris, No.105:S17b.
72. St.Louis,
M.E., Rauch, K.J., Peterson, L.R. et al. 1990. Seroprevalence rates
of Human Immunodeficiency Virus Infection at Sentinel Hospitals
in the United States. NEJM 323:213-218.
73. Chamberland,
M., Conley, L. and Dondero, T. 1988. Epidemiology of heterosexually
acquired AIDS-United States, p.264. In:Abstacts IV International
AIDS Conference,Stockholm. 74. New York City AIDS Surveillance Report,
January-March 1992.
75. Rodriquez,
L., Dewhurst, S., Sinangil, F. et al. 1985. Antibodies to HTLV-III/LAV
among Aboriginal Amazonian Indians in Venezuela. Lancet II:1098-1100.
76. Volsky,
D.J., Wu, Y.T., Stevenson, M. et al 1986. Antibodies to HTLV-III/LAV
in Venezuelan patients with acute malarial syndromes. NEJM 314:647.
77. Rous, P.
1911. A Sarcoma of the Fowl transmissible by an agent separable
from the Tumor Cells. J. Exp. Med. 13:397-411.
78. Toplin,
I. 1973. Tumor Virus Purification using Zonal Rotors. Spectra No.
4:225-235.
79. Temin,
H.M. and Baltimore, D. 1972. RNA-Directed DNA Synthesis and RNA
Tumor Viruses. Adv. Vir. Res. 17:129-186.
80. RNA Tumor
Viruses. 1982. R. Weiss, N. Teich, H. Varmus, J. Coffin (Eds.).Cold
Spring Harbor Laboratory. Cold Spring Harbor, New York.
81. Bader,
J.P. 1975. Reproduction of RNA Tumor Viruses, p.253-331. In:Comprehensive
Virology Vol.4. H. Fraenkel-Conrat, R.R. Wagner (Eds.). Plenum Press,
New York.
82. Sinoussi,
F., Mendiola, L., Chermann, J.C. et al. 1973. Purification and partial
differentiation of the particles of murine sarcoma virus (M. MSV)
according to their sedimentation rates in sucrose density gradients.
Spectra No. 4:237-243.
83. Amiesen,
J.C. and Capron, A. 1991. Cell dysfunction and depletion in AIDS:
the programmed cell death hypothesis. Immunol. Today 12:102-105.
84. Wyllie,
A.H., Kerr, J.F.R. and Currie, A.R. 1980. Cell Death:The Significance
of Apoptosis. Int. Rev. Cytol. 68:252-306.
85. Hoxie,
J.A., Fitzharris, T.P., Youngbar, P.R. et al. 1987. Nonrandom Association
of Cellular Antigens with HTLV-III Virions. Hum. Immunol. 18:39-52.
86. McKeating,
J.A. and Moore, J.P. 1991. HIV infectivity. Nature 349:660.
87. Masquelier,
B., Combeau, T. and Poveda, J. 1991. In Vitro Assays Show a Dissociation
of Reverse Transcriptase Activity and Core Antigen (p24) Production
in Two HIV-1 Isolates from a Patient Receiving Long-Term Treatment
with Zidovudine (ZDV). J. Acquir. Immun. Defic. Syndr. 4:499-505.
88. Grunow,
R., Valentin, A., Fenyo, E.M. et al. 1991. Release of HIV-1 core
protein from infected cells independent of infectious virus particles,
p.157. In:Vol. I, Abstracts VII International Conference on AIDS,Florence.
89. Tedder,
R.S., Semple, M.G., Tenant-Flowers, M. et al. 1992. HIV, AIDS, and
zidovudine. Lancet 339:805-806.
90. Lemaetre,
M., GuGtard, D., HGnin, Y. et al. 1990. Protective Activity of Tetracycline
Analogs against the Cytopathic effect of the Human Immunodeficiency
Viruses in CEM Cells. Res. Virol. 141:5-16.
91. Boulerice,
F., Bour, S., Geleziunas, R. et al. 1990. High Frequency of Isolation
of Defective Human Immunodeficiency Virus Type 1 and Heterogeneity
of Viral Gene Expression in Clones of Infected U-937 Cells. J. Virol.
64:1745-1755.
92. Ehrnst,
A., Sonnerborg, A., Bergdahl, S. and Strammegard, O. 1988. Efficient
Isolation of HIV From Plasma During Different Stages of HIV Infection.
J. Med. Virol. 26:23-32.
93. Learmont,
J., Tindall, B., Evans, L. et al. 1992. Long-term symptomless HIV-1
infection in recipients of blood products from a single donor. Lancet
340:863-867.
94. Popovic,
M., Sarngadharan, M.G., Read, E. et al. 1984. Detection, Isolation,
and Continuous Production of Cytopathic Retroviruses (HTLV-III)
from Patients with AIDS and Pre-AIDS. Science 224:497-500.
95. Gallo,
R.C., Sarin, P.S. and Wu, A.M. 1973. On the nature of the Nucleic
Acids and RNA Dependent DNA Polymerase from RNA Tumor Viruses and
Human Cells, p.13-34. In:Possible Episomes in Eukaryotes. L.G. Silvestri
(Ed.). North-Holland Publishing Company, Amsterdam.
96. Whitkin,
S.S., Higgins, P.J. and Bendich, A. 1978. Inhibition of reverse
transcriptase and human sperm DNA polymerase by anti-sperm antibodies.
Clin. Exp. Immunol. 33:244-251.
97. Tomley,
F.M., Armstrong, S.J., Mahy, B.W.J. and Owen, L.N. 1983. Reverse
transcriptase activity and particles of retroviral density in cultured
canine lymphosarcoma supernatants. Br. J. Cancer 47:277-284.
98. Weissbach,
A., Baltimore, D., Bollum, F. et al. 1975. Nomenclature of Eukaryotic
DNA Polymerases. Science 190:401-402.
99. Gallo,
R.C., Wong-Staal, F., Reitz, M. et al. 1976. Some Evidence For Infectious
Type-C Virus in Humans, p.385-407. In:Animal Virology. D. Baltimore,
A. S. Huang, C.F. Fox (Eds.). Academic Press Inc., New York.
100. Panem,
S., Prochownik, E.V., Reale, F.R. et al. 1975. Isolation of Type
C Virions from a Normal Human Fibroblast Strain. Science 189:297-299.
101. Panem,
S., Prochownik, E.V., Knish, W.M. and Kirsten, W.H. 1977. Cell Generation
and Type-C Virus Expression in the Human Embryonic Cell Strain HEL-12.
J. Gen. Virol. 35:487-495.
102. Panem,
S. 1979. C Type Virus Expression in the Placenta. Curr. Top. Pathol.
66:175-189.
103. Sarngadharan,
M.G., Robert-Guroff, M. and Gallo, R.C. 1978. DNA Polymerases of
Normal and Neoplastic Mammalian Cells. Biochim. Biophys. Acta. 516:419-487.
104. Klatzmann,
D., BarrG-Sinoussi, F., Nugeyre, M.T. et al. 1984. Selective Tropism
of Lymphadenopathy Associated Virus (LAV) for Helper-Inducer T Lymphocytes.
Science 225:59-63.
105. Montagnier,
L. 1985. Lymphadenopathy-Associated Virus:From Molecular Biology
to Pathogenicity. Ann. Int. Med. 103:689-693.
106. Gendelman,
H.E., Orenstein, J.M., Martin, M.A. et al 1988. Efficient Isolation
and Propagation of Human Immunodeficiency Virus on Recombinant Colony-Stimulating
Factor 1-Treated Monocytes. J. Exp. Med. 167:1428-1441.
107. Gelderblom,
H.R., Hausmann, E.H.S., tzel, M. et al. 1987. Fine Structure of
Human Immunodeficiency Virus (HIV) and Immunolocalization of Structural
Proteins. Virol. 156:171-176.
108. Gelderblom,
H., Reupke, H., Winkel, T. et al. 1987. MHC-Antigens:Constituents
of the Envelopes of Human and Simian Immunodeficiency Viruses. Z.
Naturforsch. 42C:1328-1334.
109. Gelderblom,
H.R., Reupke, H. and Pauli, G. 1985. Loss of envelope antigens of
HTLV-III/LAV, a factor in AIDS pathogenesis? Lancet II:1016-1017.
110. Neidrig,
M., Rabanus, J.P., L'Age Stehr, J. et al. 1988. Monoclonal Antibodies
Directed against Human Immunodeficiency Virus (HIV) gag Proteins
with Specificity for Conserved Epitopes in HIV-1, HIV-2 and Simian
Immunodeficiency Virus. J. Gen. Virol. 69:2109-2114.
111. Gelderblom,
H.R., tzel, M., Hausmann, E.H.S. et al. 1988. Fine Structure of
Human Immunodeficiency Virus (HIV),Immunolocalization of Structural
Proteins and Virus-Cell Relation. Micron Microsc. 19:41-60.
112. Meerloo,
T., Parmentier, H.K., Osterhaus, A. et al. 1992. Modulation of cell
surface molecules during HIV-1 infection of H9 cells. An immunoelectron
microscopic study. AIDS 6:1105-1116.
113. Lecatsas,
G. and Taylor, M.B. 1986. Pleomorphism in HTLV-III,the AIDS virus.
S. Afr. Med. J. 69:793-794.
114. Hockley,
D.J., Wood, R.D., Jacobs, J.P. et al. 1988. Electron Microscopy
of Human Immunodeficiency Virus. J. Gen.
Virol. 69:2455-2469.
115. Dourmashkin,
R.R., O'Toole, C.M., Bucher, D. and Oxford, J.S. 1991.The presence
of budding virus-like particles in human lymphoid cells used for
HIV cultivation. p.122. In:Vol. I, Abstracts VII International Conference
on AIDS,Florence.
116. Brennan,
J.K., Lichtman, M.A., Chamberlain, J.K. and Leblond, P. 1976. Isolation
of Variant Lymphoma Cells with Reduced Growth Requirements for Extracellular
Calcium and Magnesium and Enhanced Oncogenicity. Blood 47:447-459.
117. Garry,
R.F., Fermin, C.D., Hart, D.J. et al. 1990. Detection of a Human
Intracisternal A-Type Retroviral Particle Antigenically Related
to HIV. Science 250:1127-1129.
118. Armstrong,
J.A. and Horne, R. 1984. Follicular Dendritic Cells and Virus-Like
Particles in AIDS-Related Lymphadenopathy. Lancet II:370-372.
119. Tenner-Racz,
K., Racz, P., Bofill, M. et al. 1986. HTLV-III/LAV Viral Antigens
in Lymph Nodes of Homosexual Men With Persistent Generalized Lymphadenopathy
and AIDS. Am. J. Pathol. 123:9-15.
120. Le Tourneau,
A., Audouin, J.,Diebold, J. et al. 1986. LAV-like Viral Particles
in Lymph Node Germinal Centers in Patients with the Persistent Lymphadenopathy
Syndrome and the Acquired Immunodeficiency Syndrome-related Complex.
Hum. Pathol. 17:1047-1053.
121. O'Hara,
C.J., Groopmen, J.E. and Federman, M. 1988. The Ultrastructural
and Immunohistochemical Demonstration of Viral Particles in Lymph
Nodes from Human Immunodeficiency Virus-Related Lymphadenopathy
Syndromes. Hum. Pathol. 19:545.
122. Culliton,
B.J. 1992. The mysterious virus called "isn't". Nature
358:619.
123. Chiodi,
F., Albert, J., Olausson, E. et al. 1988. Isolation Frequency of
Human Immunodeficiency Virus from Cerebrospinal Fluid and Blood
of Patients with Varying Severity of HIV Infection. AIDS Res. Hum.
Retroviruses 4:351-358.
124. Salahuddin,
S.Z., Groopman, J.E., Markham, P.D. et al. 1984. HTLV-III Symptom-Free
Seronegative Persons. Lancet II:1418-1420.
125. Boussin,
F.,Rey, F., Dormont, D. et al. 1988. Isolation of HIV in a Seronegative
Demented Patient Without Symptoms of Immune Deficiency. Cancer Detect.
Prev. 12:257-265.
126. Bayliss,
G.J., Jesson, W.J., Evans, B.A. et al. 1989. Isolation of HIV-1
from small volumes of heparinized whole blood. AIDS 3:45-49.
127. Fiore,
J.R., Angarano, G., Fico, C. et al. 1990. Cell cultures from small
amounts of heparinized whole blood enhance HIV-1 isolation rate.
AIDS 4:1295-1296.
128. SchEpbach,
J., Jendis, J.B., Bron, C. et al. 1992. False-positive HIV-1 virus
cultures using whole blood. AIDS 6:1545-1546.
129. Hart,
C., Spira, T., Moore, J. et al. 1988. Direct Detection of HIV RNA
Expression in Seropositive Subjects. Lancet II:596-599.
130. Aaronson,
S.A., Todaro, G.J. and Scholnick, E.M. 1971. Induction of murine
C-type viruses from clonal lines of virus-free BALB/3T3 cells. Science
174:157-159.
131. Hirsch,
M.S., Phillips, S.M., Solnik, C. et al. 1972. Activation of Leukemia
Viruses by Graft-Versus-Host and Mixed Lymphocyte Reactions In Vitro.
Proc. Nat. Acad. Sci. 69:1069-1072.
132. Toyoshima,
K. and Vogt, P.K. 1969. Enhancement and Inhibition of Avian Sarcoma
Viruses by Polycations and Polyanions. Virol. 38:414-426.
133. Nakamura,
N., Sugino, H., Takahara, K. et al. 1991. Endogenous retroviral
LTR DNA sequences as markers for individual human chromosomes. Cytogenet.
Cell Genet. 57:18-22.
134. Varmus,
H. and Brown, P. 1989. Retroviruses, p.53-108. In:Mobile DNA. D.E.
Berg, M.M. Howe (Eds.). American Society for Microbiology. Washington,
D.C.
135. Weiss,
R.A., Friis, R.R., Katz, E. et al. 1971. Induction of Avian Tumor
Viruses in Normal Cells by Physical and Chemical Carcinogens. Virol.
46:920-938.
136. Temin,
H.M. 1974. On the origin of RNA Tumor Viruses. Harvey Lect. 69:173-197.
137. Wain-Hobson,
S. and Myers, G. 1990. Too close for Comfort. Nature 347:18.
138. Genetics
of RNA Tumour Viruses. 1973. p.656-699. In:The Molecular Biology
of Tumour Viruses. J. Tooze (Ed.). Cold Spring Harbor Laboratory,
Cold Spring Harbor, New York.
139. Saag,
M.S., Hahn, B.H., Gibbons, J. et al. 1988. Extensive Variation of
Human Immunodeficiency Virus Type-1 in vivo. Nature 334:440.
140. Marx,
J.L. 1988. The AIDS Virus Can Take On Many Guises. Science 241:1039-1040.
141. von Briesen,
H., Becker, W.B., Henco, K. et al. 1987. Isolation frequency and
growth properties of HIV-Variants:Multiple simultaneous variants
in a patient demonstrated by molecular cloning. J. Med. Virol. 23:51-66.
142. Bolton,
V., Pedersen, N.C., Higgins, J. et al. 1987. Unique p24 Epitope
Marker To Identify Multiple Human Immunodeficiency Virus Variants
in Blood from the Same Individuals. J. Clin. Microbiol. 25:1411-1415.
143. Wain-Hobson,
S. 1989. HIV genome variability in vivo. AIDS 3:S13-S18.
144. Innocenti,
P., Ottmann, M., Morand, P. et al. 1992. HIV-1 Blood Monocytes:
Frequency of Detection of Proviral DNA Using PCR in Comparison with
the Total CD4 Count. AIDS Res. Hum. Retroviruses 8:261-268.
145. Meyerhans,
A., Cheynier, R., Albert, J. et al. 1989. Temporal Fluctuations
in HIV quasispecies in vivo are not reflected by sequential HIV
isolations.Cell 58:901-910.
146. Robey,
W.G., Nara, P.L., Poore, C.M. et al. 1987. Rapid Assessment of Relationships
Among HIV Isolates by Oligopeptide Analyses of External Envelope
Glycoproteins. AIDS Res. Hum. Retroviruses 3:401-408.
147. Van Voorhis,
B.J., Martinez, A., Mayer, K. and Anderson, D.J. 1991. Detection
of human immunodeficiency virus type 1 in semen from seropositive
men using culture and polymerase chain reaction deoxyribonucleic
acid amplification techniques. Fertil. Steril. 55:588-594.
148. Shaw,
G.M., Hahn, B.H., Suresh, K.A. et al. 1984. Molecular Characterization
of Human T-Cell Leukemia (Lymphotropic) Virus Type III in the Acquired
Immune Deficiency Syndrome. Science 226:1165-1171.
149. Simmonds,
P., Balfe, P., Peutherer, J.F. et al.1990. Human Immunodeficiency
Virus-Infected Individuals Contain Provirus in Small Numbers of
Peripheral Mononuclear Cells and at Low Copy Numbers. J. Virol.
64:864-872.
150. Defer,
C., Agut, H., and Garbarg-Chenon, A. 1992. Multicentre quality control
of polymerase chain reaction for detection of HIV DNA. AIDS 6:659-663.
151. Becker,
J.L., Hazan, U., Nugeyre, M. T. et al. 1986. Infection of insect
lines by HIV, agent of AIDS, and evidence for HIV proviral DNA in
insects from Central Africa. C. R. Acad. Sci. Paris. 300:303-306.
152. Arya,
S.K., Gallo, R.C., Hahn, B.H. et al. 1984. Homology of Genome of
AIDS-Associated Virus with Genomes of Human T-cell Leukemia Viruses.
Science 225:927-930.
153. Mager,
D.L. and Freeman, J.D..1987. Human Endogenous Retroviruslike Genome
with Type C pol Sequences and gag Sequences Related to Human T-Cell
Lymphotropic Viruses. J. Virol. 61:4060-4066.
154 Banki,
K., Maceda, J., Hurley, E. et al. 1992. Human T-cell lymphotropic
virus (HTLV)-related endogenous sequence, HRES-1 encodes a 28-kDa
protein:A possible autoantigen for HTLV-I gag-reactive autoantibodies.
Proc. Natl. Acad. Sci. 89:1939-1943.
155. Webster,
A.D.B., Dalgleish, A.G., Beattie, R. et al. 1986. Isolation of retroviruses
from two patients with "Common Variable" Hypogammaglobulinaemia.
Lancet I:581-582.
156. Ciampolillo,
A., Marini, V. and Buscema, M. 1989. Retrovirus-like Sequences in
Graves' Disease:Implications for Human Autoimmunity. Lancet I:1096-1100.
157. Horwitz,
M.S., Boyce-Jacino, M.T. and Faras, A.J. 1992. Novel Human Endogenous
Sequences Related to Human Immunodeficiency Virus Type 1. J. Virol.
66:2170-2179.
158. Farzadegan,
H., Polis, M., Wolinsky, S.M. et al. 1988. Loss of Human Immunodeficiency
Virus Type 1 (HIV-1) Antibodies with Evidence of Viral Infection
in Asymptomatic Homosexual Men. Ann. Int. Med. 108:785-790.
159. Horsburgh,
C.R., Ou, C.Y., Holmberg, S.D. et al. 1989. Human Immunodeficiency
Virus Type 1 Infection in Homosexual Men who remain Seronegative
for prolonged periods. NEJM 321:1678-1680.
160. Mikovits,
J.A., Lohrey, N., Schuloff, R., Ruscetti, F. 1991. Immune Activation
of latent HIV-1 expression in monocyte/macrophages, p151. In:Vol.
I, Abstracts VII International Conference on AIDS,Florence.
161. Vartanian,
J.P., Meyerhans, A., Henry, M. and Wain-Hobson, S. 1992. High-resolution
structure of an HIV-1 quasispecies:identification of novel coding
sequences. AIDS 6:1095-1098.
|